Piper Sandler raised the firm’s price target on Solventum (SOLV) to $75 from $71 and keeps a Neutral rating on the shares following Q3 results. The early execution from the Solventum team is solid, and the firm is also getting a flavor of how this management team approaches setting guidance, Piper told investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV: